Remedy Pharmaceuticals Receives $9,000,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e5e41ab7-5311-4771-8b20-b26552b1e2ea - Date
12/1/2015 - Company Name
Remedy Pharmaceuticals - Mailing Address
122 West 27th Street 10th Floor New York, NY 10001 USA - Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury. - Website
http://www.remedypharmaceuticals.com - Transaction Type
Venture Equity - Transaction Amount
$9,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Funds will be used to accelerate the company’s pathway to a phase 3 study in severe stroke. - M&A Terms
- Venture Investor
The Vertical Group - Venture Investor
Undisclosed
